Syngene gets FIPB nod to raise foreign investment to 44%
Syngene, a subsidiary of Biocon, said it has received the Foreign Investment Promotion Board approval to raise foreign investment to 44 per cent.
NATIONAL STOCK EXCHANGE
-
Warburg Pincus exits MedPlus Health Services; sells 11.35 pc stake for Rs 836 cr
Private equity major Warburg Pincus on Monday exited MedPlus Health Services by selling its entire 11.35 per cent stake in the pharmacy chain for Rs 836 crore through an open market transaction. As per the bulk deal data available on the National Stock Exchange (NSE), Lavender Rose Investment Ltd, a Mauritius-based unit of Warburg Pincus, offloaded 1.35 crore shares, or its entire 11.35 per cent stake, in MedPlus Health Services.
-
India's Emcure Pharma jumps 35% in debut trade at $223 mln valuation
-
Granules India flags significant loss of revenue as it continues to recover from cyber attack
-
CDPQ pares 0.89 pc stake in Piramal Pharma for Rs 100 crore
-
Cipla stocks dive to 7-month low; here’s why bears are ruling the counter
-
Aster DM Healthcare zooms 7% on robust Q3 numbers
-
Cipla gains on resolving funding dispute with US-based Pulmatrix
-
US FDA finds quality control, equipment issues at Alembic Pharma unit
-
Max India gets NCLT nod for scheme to merge its healthcare assets into Max Healthcare
Advertisement
More in NATIONAL STOCK EXCHANGE
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
